NCT02078648 2025-02-03Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeStemline Therapeutics, Inc.Phase 1/2 Completed74 enrolled 19 charts
NCT00052715 2018-07-18Poly-ICLCSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Terminated31 enrolled 8 charts